完善个人信息
取消
| | CAS号 | |英文名称 | | 中文名称 | | 分子式 | | 分子量 |
|---|---|---|---|---|
| 312756-74-4 | 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide | 4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 | C20H16Br2N2O3S | 524.23 |
| 312917-14-9 | N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide | SC-202671 | C20H16N2OS | 332.42 |
| 2229976-21-8 | (S,R,S)-AHPC-Me-C5-COOH | (S,R,S)-AHPC-Me-C5-COOH | C30H42N4O6S | 586.74 |
| 315-30-0 | Allopurinol | 别嘌醇 | C5H4N4O | 136.11 |
| 2154342-56-8 | 4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl | 4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl | C17H21ClN4O5 | 396.83 |
| 2375194-37-7 | Pomalidomide-C6-NH2?hydrochloride | Pomalidomide-C6-NH2?hydrochloride | C19H25ClN4O4 | 408.88 |
| 2267329-76-8 | EGFR-IN-7 (compound 34) | 5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 | C32H41BrN9O2P | 694.6 |
| 2154342-45-5 | 4-[(3-Aminopropyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl | 4-[(3-Aminopropyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl | C16H19ClN4O4 | 366.79946 |
| 2166387-65-9 | BI-3802 | 顺式-2-((6-((5-氯-2-(3,5-二甲基哌嗪-1-基)嘧啶-4-基)氨基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基)氧基)-N-甲基乙酰胺 | C24H29ClN6O3 | 484.98 |
| 2166487-21-2 | SIRT5 inhibitor | 2166487-21-2 | C31H39FN6O6S2 | 674.81 |
